Jekyll and Hyde: Two faces of cannabinoid signaling in male and female fertility

Endocrine Reviews

Volumn 27, Issue 5, 2006, Pages 427-448

  Wang, Haibin ^a   Dey, Sudhansu K ^a   Maccarrone, Mauro ^b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TERAMO   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; VIRODHAMINE;

CHILDBIRTH; DRUG EFFECT; DRUG MECHANISM; EMBRYO DEVELOPMENT; EMBRYO GROWTH; EMBRYO TRANSFER; FERTILITY; FERTILIZATION; HYDROLYSIS; IMMUNOREGULATION; INFERTILITY; INNER CELL MASS; MITOSIS; NIDATION; NONHUMAN; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROGENY; REPRODUCTION; REPRODUCTIVE HEALTH; REVIEW; SERTOLI CELL; SPERMATOGENESIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EMBRYO IMPLANTATION; ENDOCANNABINOIDS; FEMALE; FERTILITY; HUMANS; LIPID METABOLISM; MALE; MODELS, BIOLOGICAL; PREGNANCY; RECEPTORS, CANNABINOID; REPRODUCTION; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 33747062387     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2006-0006     Document Type: Review

References (334)

1. Yanagimachi R 1994 Mammalian fertilization in the physiology of reproduction. In: Knobil E, Neill JD, eds. The physiology of reproduction. New York: Raven Press; 189-196
2. Evans JP, Florman HM 2002 The state of the union: the cell biology of fertilization. Nat Cell Biol 4 Suppl:s57-s63
3. Wassarman PM, Jovine L, Litscher ES 2001 A profile of fertilization in mammals. Nat Cell Biol 3:E59-E64
4. Primakoff P, Myles DG 2002 Penetration, adhesion, and fusion in mammalian sperm-egg interaction. Science 296:2183-2185
5. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, Wang H 2004 Molecular cues to implantation. Endocr Rev 25:341-373
6. Paria BC, Reese J, Das SK, Dey SK 2002 Deciphering the cross-talk of implantation: advances and challenges. Science 296:2185-2188
7. Rossant J, Tam PP 2004 Emerging asymmetry and embryonic patterning in early mouse development. Dev Cell 7:155-164
8. Wang H, Dey SK 2006 Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 7:185-199
9. Zernicka-Goetz M 2005 Developmental cell biology: cleavage pattern and emerging asymmetry of the mouse embryo. Nat Rev Mol Cell Biol 6:919-928
10. Smith WL, DeWitt DL, Garavito RM 2000 Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182
11. Wang H, Ma WG, Tejada L, Zhang H, Morrow JD, Das SK, Dey SK 2004 Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup. J Biol Chem 279:10649-10658
12. Song H, Lim H, Paria BC, Matsumoto H, Swift LL, Morrow J, Bonventre JV, Dey SK 2002 Cytosolic phospholipase A2α is crucial for 'on-time' embryo implantation that directs subsequent development. Development 129:2879-2889
13. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK 1997 Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91:197-208
14. Chakraborty I, Das SK, Wang J, Dey SK 1996 Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J Mol Endocrinol 16:107-122
15. Reese J, Paria BC, Brown N, Zhao X, Morrow JD, Dey SK 2000 Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci USA 97:9759-9764
16. Gross GA, Imamura T, Luedke C, Vogt SK, Olson LM, Nelson DM, Sadovsky Y, Muglia LJ 1998 Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc Natl Acad Sci USA 95:11875-11879
17. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, Smithies O 1995 Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483-492
18. Yu Y, Cheng Y, Fan J, Chen XS, Klein-Szanto A, Fitzgerald GA, Funk CD 2005 Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition. J Clin Invest 115:986-995
19. Matsumoto H, Ma W, Smalley W, Trzaskos J, Breyer RM, Dey SK 2001 Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biol Reprod 64:1557-1565
20. Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM, Dey SK 1999 Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev 13:1561-1574
21. Davis BJ, Lennard DE, Lee CA, Tiano HF, Morham SG, Wetsel WC, Langenbach R 1999 Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1β. Endocrinology 140:2685-2695
22. Segi E, Haraguchi K, Sugimoto Y, Tsuji M, Tsunekawa H, Tamba S, Tsuboi K, Tanaka S, Ichikawa A 2003 Expression of messenger RNA for prostaglandin E receptor subtypes EP4/EP2 and cyclooxygenase isozymes in mouse periovulatory follicles and oviducts during superovulation. Biol Reprod 68:804-811
23. Wang H, Dey SK 2005 Lipid signaling in embryo implantation. Prostaglandins Other Lipid Mediat 77:84-102
24. Shah BH, Catt KJ 2005 Roles of LPA3 and COX-2 in implantation. Trends Endocrinol Metab 16:397-399
25. Pall M, Friden BE, Brannstrom M 2001 Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod 16:1323-1328
26. Tokuyama O, Nakamura Y, Muso A, Honda K, Ishiko O, Ogita S 2001 Expression and distribution of cyclooxygenase-2 in human periovulatory ovary. Int J Mol Med 8:603-606
27. Li DK, Liu L, Odouli R 2003 Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 327:368
28. Marions L, Danielsson KG 1999 Expression of cyclo-oxygenase in human endometrium during the implantation period. Mol Hum Reprod 5:961-965
29. Critchley HO, Jones RL, Lea RG, Drudy TA, Kelly RW, Williams AR, Baird DT 1999 Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab 84:240-248
30. Challis JRG, Matthews SG, Gibb W, Lye SJ 2000 Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21:514-550
31. Slater DM, Zervou S, Thornton S 2002 Prostaglandins and prostanoid receptors in human pregnancy and parturition. J Soc Gynecol Investig 9:118-124
32. Ishii I, Fukushima N, Ye X, Chun J 2004 Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 73:321-354
33. Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T, Kennedy G, Arai H, Aoki J, Chun J 2005 LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435:104-108
34. Dey SK 2005 Reproductive biology: fatty link to fertility. Nature 435:34-35
35. Wilcox AJ, Baird DD, Weinberg CR 1999 Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 340:1796-1799
36. Paria BC, Dey SK 2000 Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids 108:211-220
37. Paria BC, Dey SK 2002 Embryonic cannabinoid receptors are targets for natural and endocannabinoids during early pregnancy. In: Onaivi ES, ed. Biology of marijuana: from gene to behavior. London: Taylor, Francis; 344-355
38. Paria BC, Wang H, Dey SK 2002 Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. Chem Phys Lipids 121:201-210
39. Maccarrone M, Falciglia K, Di Rienzo M, Finazzi-Agro A 2002 Endocannabinoids, hormone-cytokine networks and human fertility. Prostaglandins Leukot Essent Fatty Acids 66:309-317
40. Maccarrone M, Finazzi-Agro A 2004 Anandamide hydrolase: a guardian angel of human reproduction? Trends Pharmacol Sci 25:353-357
41. Maccarrone M, Wenger T 2005 Effects of cannabinoids on hypothalamic and reproductive function. Handb Exp Pharmacol 168:555-571
42. Park B, McPartland JM, Glass M 2004 Cannabis, cannabinoids and reproduction. Prostaglandins Leukot Essent Fatty Acids 70:189-197
43. Smith CG, Asch RH 1984 Acute, short-term, and chronic effects of marijuana on the female primate reproductive function. NIDA Res Monogr 44:82-96
44. Fride E, Shohami E 2002 The endocannabinoid system: function in survival of the embryo, the newborn and the neuron. Neuroreport 13:1833-1841
45. Habayeb OM, Bell SC, Konje JC 2002 Endogenous cannabinoids: metabolism and their role in reproduction. Life Sci 70:1963-1977
46. Wenger T, Toth BE, Juaneda C, Leonardelli J, Tramu G 1999 The effects of cannabinoids on the regulation of reproduction. Life Sci 65:695-701
47. Bloch E, Thysen B, Morrill GA, Gardner E, Fujimoto G 1978 Effects of cannabinoids on reproduction and development. Vitam Horm 36:203-258
48. Schuel H, Burkman LJ 2005 A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. Biol Reprod 73:1078-1086
49. Schuel H, Burkman LJ, Lippes J, Crickard K, Forester E, Piomelli D, Giuffrida A 2002 N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids 121:211-227
50. Kuczkowski KM 2004 Marijuana in pregnancy. Ann Acad Med Singapore 33:336-339
51. Nahas GG, Frick HC, Lattimer JK, Latour C, Harvey D 2002 Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa. Hum Psychopharmacol 17:103-113
52. Kolodny RC, Masters WH, Kolodner RM, Toro G 1974 Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 290:872-874
53. Hembree 3rd WC, Nahas GG, Zeidenberg P, Huang HF 1978 Changes in human spermatozoa associated with high dose marihuana smoking. Adv Biosci 22-23:429-439
54. Whan LB, West MC, McClure N, Lewis SE 2006 Effects of Δ-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro. Fertil Steril 85:653-660
55. Hong CY, Chaput de Saintonge DM, Turner P, Fairbairn JW 1982 Comparison of the inhibitory action of Δ-9-tetrahydrocannabinol and petroleum spirit extract of herbal cannabis on human sperm motility. Hum Toxicol 1:151-154
56. Issidorides MR 1978 Observations in chronic hashish users: nuclear aberrations in blood and sperm and abnormal acrosomes in spermatozoa. Adv Biosci 22-23:377-388
57. Qazi QH, Mariano E, Milman DH, Beller E, Crombleholme W 1985 Abnormalities in offspring associated with prenatal marihuana exposure. Dev Pharmacol Ther 8:141-148
58. Frank DA, Bauchner H, Parker S, Huber AM, Kyei-Aboagye K, Cabral H, Zuckerman B 1990 Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana. J Pediatr 117:622-626
59. Sherwood RA, Keating J, Kavvadia V, Greenough A, Peters TJ 1999 Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr 158:488-492
60. Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H, Parker S, Vinci R, Aboagye K, Fried LE, et al 1989 Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320:762-768
61. Fried PA, Watkinson B, Willan A 1984 Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol 150:23-27
62. Gibson GT, Baghurst PA, Colley DP 1983 Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust N Z J Obstet Gynaecol 23:15-19
63. Day N, Sambamoorthi U, Taylor P, Richardson G, Robles N, Jhon Y, Scher M, Stoffer D, Cornelius M, Jasperse D 1991 Prenatal marijuana use and neonatal outcome. Neurotoxicol Teratol 13:329-334
64. Hatch EE, Bracken MB 1986 Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 124:986-993
65. Hingson R, Alpert JJ, Day N, Dooling E, Kayne H, Morelock S, Oppenheimer E, Zuckerman B 1982 Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics 70:539-546
66. Klonoff-Cohen HS, Natarajan L, Chen RV 2006 A prospective study of the effects of female and male marijuana use on in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) outcomes. Am J Obstet Gynecol 194:369-376
67. Persaud TV, Ellington AC 1967 Cannabis in early pregnancy. Lancet 2:1306
68. Geber WF, Schramm LC 1969 Effect of marihuana extract on fetal hamsters and rabbits. Toxicol Appl Pharmacol 14:276-282
69. Paria BC, Das SK, Dey SK 1995 The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci USA 92:9460-9464
70. Persaud TV, Ellington AC 1968 The effects of Cannabis sativa L. (Ganja) on developing rat embryos-preliminary observations. West Indian Med J 17:232-234
71. Phillips RN, Turk RF, Forney RB 1971 Acute toxicity of Δ-9-tetrahydrocannabinol in rats and mice. Proc Soc Exp Biol Med 136:260-263
72. Rosenkrantz H 1978 Effects of cannabis on fetal development of rodents. Adv Biosci 22-23:479-499
73. Rosenkrantz H, Grant RJ, Fleischman RW, Baker JR 1986 Marihuana-induced embryotoxicity in the rabbit. Fundam Appl Toxicol 7:236-243
74. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG 2002 International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202
75. Pertwee RG, Ross RA 2002 Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66:101-121
76. McAllister SD, Glass M 2002 CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 66:161-171
77. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
78. Munro S, Thomas KL, Abu-Shaar M 1993 Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
79. Mechoulam R, Panikashvili D, Shohami E 2002 Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 8:58-61
80. Maccarrone M, Finazzi-Agro A 2002 Endocannabinoids and their actions. Vitam Horm 65:225-255
81. Sugiura T, Kobayashi Y, Oka S, Waku K 2002 Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 66:173-192
82. De Petrocellis L, Cascio MG, Di Marzo V 2004 The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141:765-774
83. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R 1992 Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
84. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K 1995 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97
85. Stella N, Schweitzer P, Piomelli D 1997 A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778
86. Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R 2001 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98:3662-3665
87. Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H, Waku K, Sugiura T 2003 Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J Neurochem 85:1374-1381
88. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC 2002 Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301:1020-1024
89. Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R 1998 An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 353:23-31
90. Lambert DM, Di Marzo V 1999 The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem 6:757-773
91. Hansen HH, Hansen SH, Schousboe A, Hansen HS 2000 Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons. J Neurochem 75:861-871
92. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N 2004 Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298-5305
93. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB 1996 Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83-87
94. Giang DK, Cravatt BF 1997 Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 94:2238-2242
95. Hillard CJ, Jarrahian A 2003 Cellular accumulation of anandamide: consensus and controversy. Br J Pharmacol 140:802-808
96. Ligresti A, Morera E, Van Der Stelt M, Monory K, Lutz B, Ortar G, Di Marzo V 2004 Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem J 380:265-272
97. Oddi S, Bari M, Battista N, Barsacchi D, Cozzani I, Maccarrone M 2005 Confocal microscopy and biochemical analysis reveal spatial and functional separation between anandamide uptake and hydrolysis in human keratinocytes. Cell Mol Life Sci 62:386-395
98. Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying BP, Xu YC, Phebus L, Simmons RM, Li D, Iyengar S, Felder CC 2005 Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci USA 102:17852-17857
99. Mechoulam R, Deutsch DG 2005 Toward an anandamide transporter. Proc Natl Acad Sci USA 102:17541-17542
100. Glaser ST, Kaczocha M, Deutsch DG 2005 Anandamide transport: a critical review. Life Sci 77:1584-1604
101. Battista N, Gasperi V, Fezza F, Maccarrone M 2005 The anandamide membrane transporter and the therapeutic implications of its inhibition. Therapy 2:141-150
102. Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF 2002 Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298:1793-1796
103. Maccarrone M, Bari M, Battista N, Finazzi-Agro A 2002 Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood 100:4040-4048
104. Ortega-Gutierrez S 2005 Therapeutic perspectives of inhibitors of endocannabinoid degradation. Curr Drug Targets CNS Neurol Disord 4:697-707
105. Kaczocha M, Hermann A, Glaser S, Bojesen I, Deutsch D 2006 Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by FAAH. J Biol Chem 281:9066-9075
106. McKinney MK, Cravatt BF 2005 Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-432
107. van der Stelt M, Di Marzo V 2003 The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 480:133-150
108. Di Marzo V, Matias I 2005 Endocannabinoid control of food intake and energy balance. Nat Neurosci 8:585-589
109. Di Marzo V, Bifulco M, De Petrocellis L 2004 The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:771-784
110. Piomelli D, Giuffrida A, Calignano A, Rodriguez de Fonseca F 2000 The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol Sci 21:218-224
111. Piomelli D 2003 The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884
112. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P 2003 Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463-468
113. Beltramo M, Piomelli D 2000 Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11:1231-1235
114. Hajos N, Kathuria S, Dinh T, Piomelli D, Freund TF 2004 Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404. Eur J Neurosci 19:2991-2996
115. Goparaju SK, Ueda N, Taniguchi K, Yamamoto S 1999 Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 57:417-423
116. Lichtman AH, Hawkins EG, Griffin G, Cravatt BF 2002 Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302:73-79
117. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D 2002 Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99:10819-10824
118. Ho SY, Delgado L, Storch J 2002 Monoacylglycerol metabolism in human intestinal Caco-2 cells: evidence for metabolic compartmentation and hydrolysis. J Biol Chem 277:1816-1823
119. Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, Bisogno T 2002 Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids 66:377-391
120. Caulfield MP, Brown DA 1992 Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol 106:231-232
121. Mackie K, Hille B 1992 Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829
122. Mackie K, Lai Y, Westenbroek R, Mitchell R 1995 Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561
123. Henry DJ, Chavkin C 1995 Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186:91-94
124. Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR 1999 Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am J Physiol 276:H2085-H2093
125. Wang H, Matsumoto H, Guo Y, Paria BC, Roberts RL, Dey SK 2003 Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc Natl Acad Sci USA 100:14914-14919
126. Derkinderen P, Toutant M, Kadare G, Ledent C, Parmentier M, Girault JA 2001 Dual role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus. J Biol Chem 276:38289-38296
127. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Casellas P 1995 Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 312:637-641
128. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P 1996 Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237:704-711
129. Lauckner JE, Hille B, Mackie K 2005 The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc Natl Acad Sci USA 102:19144-19149
130. Baker D, Pryce G, Davies WL, Hiley CR 2006 In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 27:1-4
131. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF 1999 Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64:193-198
132. McPartland JM, Matias I, Di Marzo V, Glass M 2006 Evolutionary origins of the endocannabinoid system. Gene 370:64-74
133. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, Kim D, Oh U 1999 Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19:529-538
134. Szallasi A, Blumberg PM 1999 Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212
135. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V 2001 The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276:12856-12863
136. Van Der Stelt M, Di Marzo V 2004 Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem 271:1827-1834
137. Jordt SE, Julius D 2002 Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 108:421-430
138. Maccarrone M, Finazzi-Agro A 2003 The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 10:946-955
139. Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, Hashiguchi T, Maruyama I 2003 Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications. Thromb Haemost 89:875-884
140. Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, Guo A, Blumberg PM, Szallasi A 2000 Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 97:3655-3660
141. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V 2002 An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400-8405
142. Guo Y, Wang H, Okamoto Y, Ueda N, Kingsley PJ, Marnett LJ, Schmid HH, Das SK, Dey SK 2005 N-Acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J Biol Chem 280:23429-23432
143. Wang J, Paria BC, Dey SK, Armant DR 1999 Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol Reprod 60:839-844
144. Murphy LL, Gher J, Steger RW, Bartke A 1994 Effects of Δ9-tetrahydrocannabinol on copulatory behavior and neuroendocrine responses of male rats to female conspecifics. Pharmacol Biochem Behav 48:1011-1017
145. Hall W, Solowij N 1998 Adverse effects of cannabis. Lancet 352:1611-1616
146. Schuel H, Burkman LJ, Lippes J, Crickard K, Mahony MC, Giuffrida A, Picone RP, Makriyannis A 2002 Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol Reprod Dev 63:376-387
147. Schuel H, Chang MC, Berkery D, Schuel R, Zimmerman AM, Zimmerman S 1991 Cannabinoids inhibit fertilization in sea urchins by reducing the fertilizing capacity of sperm. Pharmacol Biochem Behav 40:609-615
148. Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S 1994 Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci USA 91:7678-7682
149. Schuel H, Schuel R, Zimmerman AM, Zimmerman S 1987 Cannabinoids reduce fertility of sea urchin sperm. Biochem Cell Biol 65:130-136
150. Chang MC, Berkery D, Laychock SG, Schuel H 1991 Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana. III. Activation of phospholipase A2 in sperm homogenate by Δ9- tetrahydrocannabinol. Biochem Pharmacol 42:899-904
151. Chang MC, Berkery D, Schuel R, Laychock SG, Zimmerman AM, Zimmerman S, Schuel H 1993 Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction. Mol Reprod Dev 36:507-516
152. Chang MC, Schuel H 1991 Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana. II. Ultrastructural changes associated with inhibition of the acrosome reaction. Mol Reprod Dev 29:60-71
153. Zimmerman AM, Bruce WR, Zimmerman S 1979 Effects of cannabinoids on sperm morphology. Pharmacology 18:143-148
154. Dalterio S, Badr F, Bartke A, Mayfield D 1982 Cannabinoids in male mice: effects on fertility and spermatogenesis. Science 216:315-316
155. Dalterio S, Steger R, Peluso J, de Paolo L 1987 Acute Δ9-tetrahydrocannabinol exposure: effects on hypothalamic-pituitary- testicular activity in mice. Pharmacol Biochem Behav 26:533-537
156. Dalterio SL, Bartke A, Mayfield D 1983 Cannabinoids stimulate and inhibit testosterone production in vitro and in vivo. Life Sci 32:605-612
157. Dalterio S, Bartke A, Burstein S 1977 Cannabinoids inhibit testosterone secretion by mouse testes in vitro. Science 196:1472-1473
158. Patra PB, Wadsworth RM 1990 Effect of the synthetic cannabinoid nabilone on spermatogenesis in mice. Experientia 46:852-854
159. Ambrosini A, Zolese G, Wozniak M, Genga D, Boscaro M, Mantero F, Balercia G 2003 Idiopathic infertility: susceptibility of spermatozoa to in-vitro capacitation, in the presence and the absence of palmitylethanolamide (a homologue of anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. Mol Hum Reprod 9:381-388
160. Ambrosini A, Zolese G, Ambrosi S, Bertoli E, Mantero F, Boscaro M, Balercia G 2005 Idiopathic infertility: effect of palmitoylethanolamide (a homologue of anandamide) on hyperactivated sperm cell motility and Ca2+ influx. J Androl 26:429-436
161. Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K 1996 Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. Biochem Biophys Res Commun 218:113-117
162. Gye MC, Kang HH, Kang HJ 2005 Expression of cannabinoid receptor 1 in mouse testes. Arch Androl 51:247-255
163. Wenger T, Ledent C, Csernus V, Gerendai I 2001 The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem Biophys Res Commun 284:363-368
164. Newton SC, Murphy LL, Bartke A 1993 In vitro effects of psychoactive and non-psychoactive cannabinoids on immature rat Sertoli cell function. Life Sci 53:1429-1437
165. Orth JM, McGuinness MP, Qiu J, Jester Jr WF, Li LH 1998 Use of in vitro systems to study male germ cell development in neonatal rats. Theriogenology 49:431-439
166. Maccarrone M, Cecconi S, Rossi G, Battista N, Pauselli R, Finazzi-Agro A 2003 Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 144:20-28
167. O'Bryan MK, Schlatt S, Gerdprasert O, Phillips DJ, de Kretser DM, Hedger MP 2000 Inducible nitric oxide synthase in the rat testis: evidence for potential roles in both normal function and inflammation-mediated infertility. Biol Reprod 63:1285-1293
168. Herrero MB, de Lamirande E, Gagnon C 2001 Tyrosine nitration in human spermatozoa: a physiological function of peroxynitrite, the reaction product of nitric oxide and superoxide. Mol Hum Reprod 7:913-921
169. Fujisawa M, Yamanaka K, Tanaka H, Tanaka H, Okada H, Arakawa S, Kamidono S 2001 Expression of endothelial nitric oxide synthase in the Sertoli cells of men with infertility of various causes. BJU Int 87:85-88
170. Bisogno T, Ventriglia M, Milone A, Mosca M, Cimino G, Di Marzo V 1997 Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus. Biochim Biophys Acta 1345:338-348
171. Schuel H, Berkery D, Schuel R, Chang MC, Zimmerman AM, Zimmerman S 1991 Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana. I. Inhibition of the acrosome reaction induced by egg jelly. Mol Reprod Dev 29:51-59
172. Fukami K, Yoshida M, Inoue T, Kurokawa M, Fissore RA, Yoshida N, Mikoshiba K, Takenawa T 2003 Phospholipase Cδ4 is required for Ca2+ mobilization essential for acrosome reaction in sperm. J Cell Biol 161:79-88
173. Wennemuth G, Babcock DF, Hille B 2003 Calcium clearance mechanisms of mouse sperm. J Gen Physiol 122:115-128
174. Gadella BM, Harrison RA 2000 The capacitating agent bicarbonate induces protein kinase A-dependent changes in phospholipid transbilayer behavior in the sperm plasma membrane. Development 127:2407-2420
175. Suarez SS, Ho HC 2003 Hyperactivated motility in sperm. Reprod Domest Anim 38:119-124
176. Rossato M, Ion Popa F, Ferigo M, Clari G, Foresta C 2005 Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab 90:984-991
177. Barboni B, Mattioli M, Seren E 1995 Influence of progesterone on boar sperm capacitation. J Endocrinol 144:13-18
178. Mattioli M, Barboni B, Lucidi P, Seren E 1996 Identification of capacitation in boar spermatozoa by chlortetracycline staining. Theriogenology 45:373-377
179. James PS, Hennessy C, Berge T, Jones R 2004 Compartmentalisation of the sperm plasma membrane: a FRAP, FLIP and SPFI analysis of putative diffusion barriers on the sperm head. J Cell Sci 117:6485-6495
180. Maccarrone M, Barboni B, Paradisi A, Bernabo N, Gasperi V, Pistilli MG, Fezza F, Lucidi P, Mattioli M 2005 Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J Cell Sci 118:4393-4404
181. Rossant J 2004 Lineage development and polar asymmetries in the peri-implantation mouse blastocyst. Semin Cell Dev Biol 15:573-581
182. Cross JC, Werb Z, Fisher SJ 1994 Implantation and the placenta: key pieces of the development puzzle. Science 266:1508-1518
183. Norwitz ER, Schust DJ, Fisher SJ 2001 Implantation and the survival of early pregnancy. N Engl J Med 345:1400-1408
184. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC 1988 Incidence of early loss of pregnancy. N Engl J Med 319:189-194
185. Carson DD, Bagchi I, Dey SK, Enders AC, Fazleabas AT, Lessey BA, Yoshinaga K 2000 Embryo implantation. Dev Biol 223:217-237
186. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ 2004 Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 114:744-754
187. Das SK, Paria BC, Chakraborty I, Dey SK 1995 Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 92:4332-4336
188. Paria BC, Song H, Wang X, Schmid PC, Krebsbach RJ, Schmid HH, Bonner TI, Zimmer A, Dey SK 2001 Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem 276:20523-20528
189. Wang H, Guo Y, Wang D, Kingsley PJ, Marnett LJ, Das SK, DuBois RN, Dey SK 2004 Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med 10:1074-1080
190. Yang ZM, Paria BC, Dey SK 1996 Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol Reprod 55:756-761
191. Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, Deng H, Makriyannis A, Dey SK 1998 Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod 58:1490-1495
192. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrarab P, Soubriea P, Brelierea JC, Le Fur GL 1994 SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
193. Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Breliere JC, Le Fur GL 1998 SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 284:644-650
194. Sharov AA, Piao Y, Matoba R, Dudekula DB, Qian Y, VanBuren V, Falco G, Martin PR, Stagg CA, Bassey UC, Wang Y, Carter MG, Hamatani T, Aiba K, Akutsu H, Sharova L, Tanaka TS, Kimber WL, Yoshikawa T, Jaradat SA, Pantano S, Nagaraja R, Boheler KR, Taub D, Hodes RJ, Longo DL, Schlessinger D, Keller J, Klotz E, Kelsoe G, Umezawa A, Vescovi AL, Rossant J, Kunath T, Hogan BL, Curci A, D'Urso M, Kelso J, Hide W, Ko MS 2003 Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol 1:E74
195. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI 1999 Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96:5780-5785
196. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G 1999 Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96:14136-14141
197. Farquhar CM 2005 Ectopic pregnancy. Lancet 366:583-591
198. Pisarska MD, Carson SA, Buster JE 1998 Ectopic pregnancy. Lancet 351:1115-1120
199. Heilman RD, Reo RR, Hahn DW 1976 Changes in the sensitivity of adrenergic receptors in the oviduct during early gestation in the rabbit. Fertil Steril 27:426-430
200. Howe GR, Black DL 1973 Autonomic nervous system and oviduct function in the rabbit. I. Hormones and contraction. J Reprod Fertil 33:425-430
201. Kennedy DR, Marshall JM 1977 Effect of adrenergic nerve stimulation on the rabbit oviduct: correlation with norepinephrine content and turnover rate. Biol Reprod 16:200-211
202. Paria BC, Huet-Hudson YM, Dey SK 1993 Blastocyst's state of activity determines the "window" of implantation in the receptive mouse uterus. Proc Natl Acad Sci USA 90:10159-10162
203. Paria BC, Lim H, Wang XN, Liehr J, Das SK, Dey SK 1998 Coordination of differential effects of primary estrogen and catecholestrogen on two distinct targets mediates embryo implantation in the mouse. Endocrinology 139:5235-5246
204. Das SK, Wang XN, Paria BC, Damm D, Abraham JA, Klagsbrun M, Andrews GK, Dey SK 1994 Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 120:1071-1083
205. Yoshinaga K, Adams CE 1966 Delayed implantation in the spayed, progesterone treated adult mouse. J Reprod Fertil 12:593-595
206. McLaren 1971 A Blastocysts in the mouse uterus: the effect of ovariectomy, progesterone and oestrogen. J Endocrinol 50:515-526
207. Schmid PC, Paria BC, Krebsbach RJ, Schmid HH, Dey SK 1997 Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci USA 94:4188-4192
208. Liu WM, Duan EK, Cao YJ 2002 Effects of anandamide on embryo implantation in the mouse. Life Sci 71:1623-1632
209. Habayeb OM, Taylor AH, Evans MD, Cooke MS, Taylor DJ, Bell SC, Konje JC 2004 Plasma levels of the endocannabinoid anandamide in women-a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 89:5482-5487
210. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D 1994 Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691
211. Maccarrone M, DeFelici M, Klinger FG, Battista N, Fezza F, Dainese E, Siracusa G, Finazzi-Agro A 2004 Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus. Mol Hum Reprod 10:215-221
212. Paria BC, Deutsch DD, Dey SK 1996 The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol Reprod Dev 45:183-192
213. Paria BC, Zhao X, Wang J, Das SK, Dey SK 1999 Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. Biol Reprod 60:1151-1157
214. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A 2000 Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355:1326-1329
215. Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna C, Di Marzo V, Finazzi-Agro A 2002 Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 8:188-195
216. Kessler CA, Moghadam KK, Schroeder JK, Buckley AR, Brar AK, Handwerger S 2005 Cannabinoid receptor I activation markedly inhibits human decidualization. Mol Cell Endocrinol 229:65-74
217. Breivogel CS, Griffin G, Di Marzo V, Martin BR 2001 Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155-163
218. Bari M, Battista N, Fezza F, Gasperi V, Maccarrone M 2006 New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 6:257-268
219. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S 1998 Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 4:1020-1024
220. Sharkey A 1998 Cytokines and implantation. Rev Reprod 3:52-61
221. Szekeres-Bartho J, Faust Z, Varga P, Szereday L, Kelemen K 1996 The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 35:348-351
222. Chaouat G, Menu E, Delage G, Moreau JF, Khrishnan L, Hui L, Meliani AA, Martal J, Raghupathy R, Lelaidier C, Bertrand C, Freitas S, Hambartsumian E, Wegmann TG, Frydman R 1995 Immuno-endocrine interactions in early pregnancy. Hum Reprod 10(Suppl 2):55-59
223. Stewart CL, Cullinan EB 1997 Preimplantation development of the mammalian embryo and its regulation by growth factors. Dev Genet 21:91-101
224. Duval D, Reinhardt B, Kedinger C, Boeuf H 2000 Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF)-dependent embryonic stem cell survival. FASEB J 14:1577-1584
225. Taupin JL, Minvielle S, Thèze J, Jacques Y, Moreau JF 1999 The interleukin-6 family of cytokines and their receptors. In: Thèze J, ed. The cytokine network and immune functions. New York: Oxford University Press; 31-44
226. Cravatt BF, Lichtman AH 2003 Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 7:469-475
227. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A 2001 Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J Immunol 166:7183-7189
228. Lazzarin N, Valensise H, Bari M, Ubaldi F, Battista N, Finazzi-Agro A, Maccarrone M 2004 Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol Endocrinol 18:212-218
229. Piccinni MP, Romagnani S 1996 Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines. Immunol Res 15:141-150
230. Maccarrone M, Bari M, Di Rienzo M, Finazzi-Agro A, Rossi A 2003 Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J Biol Chem 278:32726-32732
231. Ahima RS, Flier JS2000 Leptin. Annu Rev Physiol 62:413-437
232. Matarese G, La Cava A, Sanna V, Lord GM, Lechler RI, Fontana S, Zappacosta S 2002 Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol 23:182-187
233. Maccarrone M, Di Rienzo M, Finazzi-Agro A, Rossi A 2003 Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3. J Biol Chem 278:13318-13324
234. MacCarrone M, De Felici M, Bari M, Klinger F, Siracusa G, Finazzi-Agro A 2000 Down-regulation of anandamide hydrolase in mouse uterus by sex hormones. Eur J Biochem 267:2991-2997
235. Maccarrone M, Fride E, Bisogno T, Bari M, Cascio MG, Battista N, Finazzi Agro A, Suris R, Mechoulam R, Di Marzo V 2005 Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. Mol Hum Reprod 11:21-28
236. Kline J, Stein Z, Susser ME 1989 Conception to birth: epidemiology of prenatal development. New York: Oxford University Press
237. Sozio J, Ness RB 1998 Chlamydial lower genital tract infection and spontaneous abortion. Infect Dis Obstet Gynecol 6:8-12
238. Walsh RA 1994 Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation. Hum Biol 66:1059-1092
239. Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL, Kline J 1999 Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 340:333-339
240. Iversen L 2003 Cannabis and the brain. Brain 126:1252-1270
241. Di Carlo G, Izzo AA 2003 Cannabinoids for gastrointestinal diseases: potential therapeutic applications. Expert Opin Investig Drugs 12:39-49
242. Fowler CJ 2004 Possible involvement of the endocannabinoid system in the actions of three clinically used drugs. Trends Pharmacol Sci 25:59-61
243. Tsuboi K, Sun YX, Okamoto Y, Araki N, Tonai T, Ueda N 2005 Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 280:11082-11092
244. Bifulco M, Di Marzo V 2002 Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat Med 8:547-550
245. Guzman M 2003 Cannabinoids: potential anticancer agents. Nat Rev Cancer 3:745-755
246. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D 2003 Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81
247. Freund TF, Katona I, Piomelli D 2003 Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-1066
248. van der Stelt M, Veldhuis WB, Maccarrone M, Bar PR, Nicolay K, Veldink GA, Di Marzo V, Vliegenthart JF 2002 Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol Neurobiol 26:317-346
249. Wilson RI, Nicoll RA 2002 Endocannabinoid signaling in the brain. Science 296:678-682
250. Hamatani T, Carter MG, Sharov AA, Ko MS 2004 Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell 6:117-131
251. Hamatani T, Daikoku T, Wang H, Matsumoto H, Carter MG, Ko MS, Dey SK 2004 Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proc Natl Acad Sci USA 101:10326-10331
252. Ko MS, Kitchen JR, Wang X, Threat TA, Wang X, Hasegawa A, Sun T, Grahovac MJ, Kargul GJ, Lim MK, Cui Y, Sano Y, Tanaka T, Liang Y, Mason S, Paonessa PD, Sauls AD, DePalma GE, Sharara R, Rowe LB, Eppig J, Morrell C, Doi H 2000 Large-scale cDNA analysis reveals phased gene expression patterns during preimplantation mouse development. Development 127:1737-1749
253. Carter MG, Hamatani T, Sharov AA, Carmack CE, Qian Y, Aiba K, Ko NT, Dudekula DB, Brzoska PM, Hwang SS, Ko MS 2003 In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling. Genome Res 13:1011-1021
254. Carter MG, Piao Y, Dudekula DB, Qian Y, VanBuren V, Sharov AA, Tanaka TS, Martin PR, Bassey UC, Stagg CA, Aiba K, Hamatani T, Matoba R, Kargul GJ, Ko MS 2003 The NIA cDNA project in mouse stem cells and early embryos. C R Biol 326:931-940
255. Wang QT, Piotrowska K, Ciemerych MA, Milenkovic L, Scott MP, Davis RW, Zernicka-Goetz M 2004 A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo. Dev Cell 6:133-144
256. Zeng F, Baldwin DA, Schultz RM 2004 Transcript profiling during preimplantation mouse development. Dev Biol 272:483-496
257. Cravatt BF, Saghatelian A, Hawkins EG, Clement AB, Bracey MH, Lichtman AH 2004 Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc Natl Acad Sci USA 101:10821-10826
258. Fernandez-Solari J, Scorticati C, Mohn C, De Laurentiis A, Billi S, Franchi A, McCann SM, Rettori V 2004 Alcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid system. Proc Natl Acad Sci USA 101:3264-3268
259. Gammon CM, Freeman Jr GM, Xie W, Petersen SL, Wetsel WC 2005 Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 146:4491-4499
260. Scorticati C, Fernandez-Solari J, De Laurentiis A, Mohn C, Prestifilippo JP, Lasaga M, Seilicovich A, Billi S, Franchi A, McCann SM, Rettori V 2004 The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proc Natl Acad Sci USA 101:11891-11896
261. Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, Marnett LJ 2002 Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277:44877-44885
262. Yu M, Ives D, Ramesha CS 1997 Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 272:21181-21186
263. van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agro A, Vliegenthart JF, Maccarrone M 2002 Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J Med Chem 45:3709-3720
264. Ueda N, Yamamoto K, Yamamoto S, Tokunaga T, Shirakawa E, Shinkai H, Ogawa M, Sato T, Kudo I, Inoue K, Takizawa H, Nagano T, Hirobe M, Matsuki N, Saito H 1995 Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim Biophys Acta 1254:127-134
265. Maccarrone M, Salvati S, Bari M, Finazzi A 2000 Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. Biochem Biophys Res Commun 278:576-583
266. Dalterio S, Bartke A, Roberson C, Watson D, Burstein S 1978 Direct and pituitary-mediated effects of Δ9-THC and cannabinol on the testis. Pharmacol Biochem Behav 8:673-678
267. Wenger T, Rettori V, Snyder GD, Dalterio S, McCann SM 1987 Effects of Δ-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle-stimulating hormone secretion in adult male rats. Neuroendocrinology 46:488-493
268. Chakravarty I, Sheth PR, Sheth AR, Ghosh JJ 1982 Δ-9- Tetrahydrocannabinol: its effect on hypothalamo-pituitary system in male rats. Arch Androl 8:25-27
269. Murphy LL, Adrian BA, Kohli M 1999 Inhibition of luteinizing hormone secretion by Δ9-tetrahydrocannabinol in the ovariectomized rat: effect of pretreatment with neurotransmitter or neuropeptide receptor antagonists. Steroids 64:664-671
270. Steger RW, Murphy LL, Bartke A, Smith MS 1990 Effects of psychoactive and nonpsychoactive cannabinoids on the hypothalamic-pituitary axis of the adult male rat. Pharmacol Biochem Behav 37:299-302
271. Marks BH 1973 Δ1-Tetrahydrocannabinol and luteinizing hormone secretion. Prog Brain Res 39:331-338
272. Symons AM, Teale JD, Marks V 1976 Proceedings: Effect of Δ9-tetrahydrocannabinol on the hypothalamic-pituitary-gonadal system in the maturing male rat. J Endocrinol 68:43P-44P
273. Collu R, Letarte J, Leboeuf F, Ducharme JR 1975 Endocrine effects of chronic administration of psychoactive drugs to prepuberal male rats. I: Δ9-tetrahydrocannabinol. Life Sci 16:533-542
274. Smith CG, Moore CE, Besch NF, Besch PK 1976 The effect of marihuana Δ-9-tetrahydrocannabinol on the secretion of sex hormones in the mature male rhesus monkey. Clin Chem 22:1184
275. Kramer J, Ben-David M 1974 Suppression of prolactin secretion by acute administration of Δ9-THC in rats. Proc Soc Exp Biol Med 147:482-484
276. Dalterio SL, Michael SD, Macmillan BT, Bartke A 1981 Differential effects of cannabinoid exposure and stress on plasma prolactin, growth hormone and corticosterone levels in male mice. Life Sci 28:761-766
277. Asch RH, Smith CG, Siler-Khodr TM, Pauerstein CJ 1979 Acute decreases in serum prolactin concentrations caused by Δ 9-tetrahydrocannabinol in nonhuman primates. Fertil Steril 32:571-575
278. List A, Nazar B, Nyquist S, Harclerode J 1977 The effects of Δ9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat. Drug Metab Dispos 5:268-272
279. Harclerode J, Nyquist SE, Nazar B, Lowe D 1978 Effects of cannabis on sex hormones and testicular enzymes of the rodent. Adv Biosci 22-23:395-405
280. Rosenkrantz H, Esber HJ 1980 Cannabinoid-induced hormone changes in monkeys and rats. J Toxicol Environ Health 6:297-313
281. Fujimoto GI, Morrill GA, O'Connell ME, Kostellow AB, Retura G 1982 Effects of cannabinoids given orally and reduced appetite on the male rat reproductive system. Pharmacology 24:303-313
282. Thompson GR, Fleischman RW, Rosenkrantz H, Braude MC 1974 Oral and intravenous toxicity of Δ9-tetrahydrocannabinol in rhesus monkeys. Toxicol Appl Pharmacol 27:648-665
283. Maskarinec MP, Shipley G, Novotny M, Brown DJ, Forney RB 1978 Different effects of synthetic Δ9-tetrahydrocannabinol and cannabis extract on steroid metabolism in male rats. Experientia 34:88-89
284. Rosenkrantz H, Fleischman RW, Grant RJ 1981 Toxicity of short-term administration of cannabinoids to rhesus monkeys. Toxicol Appl Pharmacol 58:118-131
285. Dixit VP, Gupta CL, Agrawal M 1977 Testicular degeneration and necrosis induced by chronic administration of cannabis extract in dogs. Endokrinologie 69:299-305
286. Rosenkrantz H, Hayden DW 1979 Acute and subacute inhalation toxicity of Turkish marihuana, cannabichromene, and cannabidiol in rats. Toxicol Appl Pharmacol 48:375-386
287. Dixit VP, Jain HC, Verma OP, Sharma AN 1977 Effects of cannabis extract on the testicular function of the toad Bufo andersonii Boulenger. Indian J Exp Biol 15:555-557
288. Dixit VP, Sharma VN, Lohiya NK 1974 The effect of chronically administered cannabis extract on the testicular function of mice. Eur J Pharmacol 26:111-114
289. Vyas DK, Singh R 1976 Effect of cannabis, opium on the testis of the pigeon Columba livia Gmelin. Indian J Exp Biol 14:22-25
290. Okey AB, Truant GS 1975 Cannabis demasculinizes rats but is not estrogenic. Life Sci 17:1113-1117
291. Zimmerman AM, Zimmerman S, Raj AY 1978 Effects of cannabinoids on spermatogenesis in mice. Adv Biosci 22-23:407-418
292. Huang HF, Nahas GG, Hembree 3rd WC 1978 Effects of marihuana inhalation on spermatogenesis of the rat. Adv Biosci 22-23:419-427
293. Tilak SK, Zimmerman AM 1984 Effects of cannabinoids on macromolecular synthesis in isolated spermatogenic cells. Pharmacology 29:343-350
294. Merari A, Barak A, Plaves M 1973 Effects of 1(2) -tetrahydrocannabinol on copulation in the male rat. Psychopharmacologia 28:243-246
295. Corcoran ME, Amit Z, Malsbury CW, Daykin S 1974 Reduction in copulatory behavior of male rats following hashish injections. Res Commun Chem Pathol Pharmacol 7:779-782
296. Cone EJ, Johnson RE, Moore JD, Roache JD 1986 Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol Biochem Behav 24:1749-1754
297. Vescovi PP, Pedrazzoni M, Michelini M, Maninetti L, Bernardelli F, Passeri M 1992 Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol Depend 30:59-63
298. Harmon J, Aliapoulios MA 1972 Gynecomastia in marihuana users. N Engl J Med 287:936
299. Smith CG, Besch NF, Smith RG, Besch PK 1979 Effect of tetrahydrocannabinol on the hypothalamic-pituitary axis in the ovariectomized rhesus monkey. Fertil Steril 31:335-339
300. Ayalon D, Nir I, Cordova T, Bauminger S, Puder M, Naor Z, Kashi R, Zor U, Harell A, Lindner HR 1977 Acute effect of Δ1-tetrahydrocannabinol on the hypothalamo-pituitary-ovarian axis in the rat. Neuroendocrinology 23:31-42
301. Dalterio SL, Mayfield DL, Bartke A 1983 Effects of Δ 9-THC on plasma hormone levels in female mice. Subst Alcohol Actions Misuse 4:339-345
302. Nir I, Ayalon D, Tsafriri A, Cordova T, Lindner HR 1973 Letter: Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by Δ 1-tetrahydrocannabinol. Nature 243:470-471
303. Tyrey L 1978 Δ-9-Tetrahydrocannabinol suppression of episodic luteinizing hormone secretion in the ovariectomized rat. Endocrinology 102:1808-1814
304. Smith CG, Smith MT, Besch NF, Smith RG, Asch RH 1978 Effect of Δ 9-tetrahydrocannabinol (THC) on female reproductive function. Adv Biosci 22-23:449-467
305. Jackson AL, Murphy LL 1997 Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by Δ-9- tetrahydrocannabinol. Neuroendocrinology 65:446-452
306. Chakravarty I, Sheth AR, Ghosh JJ 1975 Effect of acute Δ9-tetrahydrocannabinol treatment on serum luteinizing hormone and prolactin levels in adult female rats. Fertil Steril 26:947-948
307. Tyrey L 1992 Δ-9-Tetrahydrocannabinol attenuates luteinizing hormone release induced by electrochemical stimulation of the medial preoptic area. Biol Reprod 47:262-267
308. Besch NF, Smith CG, Besch PK, Kaufman RH 1977 The effect of marihuana (Δ-9-tetrahydrocannabinol) on the secretion of luteinizing hormone in the ovariectomized rhesus monkey. Am J Obstet Gynecol 128:635-642
309. Hughes Jr CL, Everett JW, Tyrey L 1981 Δ 9-Tetrahydrocannabinol suppression of prolactin secretion in the rat: lack of direct pituitary effect. Endocrinology 109:876-880
310. Chakravarty I, Shah PG, Sheth AR, Ghosh JJ 1979 Mode of action of Δ-9-tetrahydrocannabinol on hypothalamo-pituitary function in adult female rats. J Reprod Fertil 57:113-115
311. Almirez RG, Smith CG, Asch RH 1983 The effects of marijuana extract and Δ 9-tetrahydrocannabinol on luteal function in the rhesus monkey. Fertil Steril 39:212-217
312. Kostellow AB, Ziegler D, Kunar J, Fujimoto GI, Morrill GA 1980 Effect of cannabinoids on estrous cycle, ovulation and reproductive capacity of female A/J mice. Pharmacology 21:68-75
313. Asch RH, Smith CG, Siler-Khodr TM, Pauerstein CJ 1981 Effects of Δ 9-tetrahydrocannabinol during the follicular phase of the rhesus monkey (Macaca mulatta). J Clin Endocrinol Metab 52:50-55
314. Asch RH, Fernandez EO, Smith CG, Pauerstein CJ 1979 Precoital single doses of Δ9-tetrahydrocannabinol block ovulation in the rabbit. Fertil Steril 31:331-334
315. Dixit VP, Arya M, Lohiya NK 1975 The effect of chronically administered cannabis extract on the female genital tract of mice and rats. Endokrinologie 66:365-368
316. Wenger T, Croix D, Tramu G 1988 The effect of chronic prepubertal administration of marihuana (Δ-9-tetrahydrocannabinol) on the onset of puberty and the postpubertal reproductive functions in female rats. Biol Reprod 39:540-545
317. Field E, Tyrey L 1984 Delayed sexual maturation in the female rat during chronic exposure to Δ-9-tetrahydrocannabinol. Life Sci 35:1725-1730
318. Mani SK, Mitchell A, O'Malley BW 2001 Progesterone receptor and dopamine receptors are required in Δ 9-tetrahydrocannabinol modulation of sexual receptivity in female rats. Proc Natl Acad Sci USA 98:1249-1254
319. Gordon JH, Bromley BL, Gorski RA, Zimmermann E 1978 Δ9- Tetrahydrocannabinol enhancement of lordosis behavior in estrogen treated female rats. Pharmacol Biochem Behav 8:603-608
320. Turley Jr WA, Floody OR 1981 Δ-9-Tetrahydrocannabinol stimulates receptive and proceptive sexual behaviors in female hamsters. Pharmacol Biochem Behav 14:745-747
321. Asch RH, Smith CG 1986 Effects of Δ 9-THC, the principal psychoactive component of marijuana, during pregnancy in the rhesus monkey. J Reprod Med 31:1071-1081
322. Sassenrath EN, Chapman LF, Goo GP 1978 Reproduction in rhesus monkeys chronically exposed to Δ-9-tetrahydrocannabinol. Adv Biosci 22-23:501-512
323. Abel EL, Tan SE 1987 Effects of Δ-9-tetrahydrocannabinol, chlordiazepoxide (Librium), and their combination on pregnancy and offspring in mice [correction of rats]. Reprod Toxicol 1:37-40
324. Harbison RD, Mantilla-Plata B 1972 Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J Pharmacol Exp Ther 180:446-453
325. Abel EL, Tan SE, Subramanian M 1987 Effects of Δ 9-tetrahydrocannabinol, phenobarbital, and their combination on pregnancy and offspring in rats. Teratology 36:193-198
326. Wenger T, Fragkakis G, Giannikou P, Probonas K, Yiannikakis N1997 Effects of anandamide on gestation in pregnant rats. Life Sci 60:2361-2371
327. Tyrey L, Murphy LL 1988 Inhibition of suckling-induced milk ejections in the lactating rat by Δ 9-tetrahydrocannabinol. Endocrinology 123:469-472
328. Mendelson JH, Mello NK, Ellingboe J, Skupny AS, Lex BW, Griffin M 1986 Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther 237:862-866
329. Mendelson JH, Mello NK 1984 Effects of marijuana on neuroendocrine hormones in human males and females. NIDA Res Monogr 44:97-114
330. Mendelson JH, Mello NK, Ellingboe J 1985 Acute effects of marihuana smoking on prolactin levels in human females. J Pharmacol Exp Ther 232:220-222
331. Bauman J 1980 Marijuana and the female reproductive system. In: Health consequence of marijuana use. Washington DC: U.S. Government Printing Office; 85-97
332. Greenland S, Staisch KJ, Brown N, Gross SJ 1982 Effects of marijuana on human pregnancy, labor, and delivery. Neurobehav Toxicol Teratol 4:447-450
333. Greenland S, Staisch KJ, Brown N, Gross SJ 1982 The effects of marijuana use during pregnancy. I. A preliminary epidemiologic study. Am J Obstet Gynecol 143:408-413
334. Greenland S, Richwald GA, Honda GD 1983 The effects of marijuana use during pregnancy. II. A study in a low-risk home-delivery population. Drug Alcohol Depend 11:359-366